Dow Jones
39.394,22 +337,83 (+0,86%) Nasdaq
16.339,58 +36,83 (+0,23%) Nikkei 225
38.073,98 -128,39 (-0,34%) EUR/USD
1,0786 +0,0035 (+0,32%) Bitcoin EUR
57.919,71 +148,07 (+0,26%) CMC Crypto 200
1.342,16 +42,07 (+3,24%)
The Oncology Institute, Inc. (TOI)
| Chiusura precedente | 0,9185 |
| Aperto | 0,9200 |
| Denaro | 0,9051 x 100 |
| Lettera | 0,9859 x 100 |
| Min-Max giorno | 0,9200 - 0,9581 |
| Intervallo di 52 settimane | 0,3300 - 2,6550 |
| Volume | |
| Media Volume | 125.221 |
| Capitalizzazione | 71,2M |
| Beta (5 anni mensile) | 0,83 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,9200 |
| Prossima data utili | 14 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireThe Oncology Institute Names Jeremy Castle as Chief Operations Officer
CERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, 2023. In this role, Mr. Castle leads enterprise field and central operations, pharmacy, real estate, and practice integration, playing a key role in driving TOI’s success as a public company. Mr. Castle joins TOI with over 15 years of oncology industry experience, and has a track record of driving g
- GlobeNewswire
The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit
CERRITOS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (TOI) is excited to announce that multiple executives including CEO, Dr. Daniel Virnich, CMO, Dr. Yale Podnos, and other senior clinical leaders, will be participating in the Association for Value-Based Cancer Care (AVBCC) Summit. The 2023 AVBCC Summit features keynote speakers, interactive panel discussions, and informative sessions designed to foster collaboration, innovation and progress in the
- GlobeNewswire
The Oncology Institute Regains Compliance with Nasdaq Listing Requirements
CERRITOS, California, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI) (the “Company”), one of the largest value-based community oncology groups in the United States, today announced that it received written notice from the Listing Qualifications Staff of The Nasdaq Stock Market (“Nasdaq”) on September 15, 2023, informing the Company that it has regained compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 550(a)(2) (the “Rule”) for continu
